Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trivalent metal ions are chemical entities characterized by a +3 oxidation state, including biologically essential ions like ferric iron (Fe3+) and non-essential ions like aluminum (Al3+) and lanthanum (La3+). Ferric iron is a fundamental cofactor for numerous proteins involved in oxygen transport, such as hemoglobin, and enzymes critical for DNA synthesis and cellular respiration (StatPearls, 2023). However, the accumulation of trivalent ions can be highly toxic; for instance, excess iron leads to the generation of reactive oxygen species and subsequent organ damage, while aluminum accumulation is linked to neurotoxicity and bone disease (ATSDR, 2008). Consequently, trivalent metal ions serve as the primary targets for chelation therapy, where drugs like deferoxamine and deferasirox are employed to sequester these ions and facilitate their removal from the body (PubChem, 2024). Additionally, trivalent ions like lanthanum are used therapeutically as phosphate binders to treat hyperphosphatemia in chronic kidney disease (FDA, 2011). Understanding the homeostasis and pharmacological targeting of these ions is crucial for managing conditions like hereditary hemochromatosis, transfusion-dependent anemias, and accidental metal poisoning.
The primary mechanism of action involves the sequestration of trivalent metal ions by chelating agents to form stable, non-toxic complexes that are excreted from the body. Alternatively, trivalent metal ions like lanthanum or aluminum act as phosphate binders by forming insoluble complexes with dietary phosphate in the gastrointestinal tract, preventing its absorption (FDA, 2011; StatPearls, 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trivalent metal ion (M3+).